Neurofeedback for Mild Cognitive Impairment
Trial Summary
What is the purpose of this trial?
The goal of this pilot study is to determine the feasibility, acceptability and potential impact of using neurofeedback interventions to manage cognitive, emotional, and behavioural symptoms in individuals with mild cognitive impairment (MCI). The main question\[s\] it aims to answer are: (1) What is the feasibility, acceptability, and appropriateness of using the Nonlinear Dynamical Neurofeedback intervention for persons living with MCI? (2) What is the feasibility, acceptability, and appropriateness of using the Low Energy Neurofeedback System (LENS) intervention for persons living with MCI? (3) What is the feasibility, acceptability, and appropriateness of using the Brain Music neurofeedback intervention for persons living with MCI? (4) What is the potential impact of five weeks of a neurofeedback intervention on cognitive, affective, and behavioural symptoms experienced by persons living with MCI? Participants will be randomly assigned to either the Nonlinear Dynamical (NLD), Low Energy Neurofeedback System (LENS), or Brain Music neurofeedback intervention groups or a control group receiving usual care.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Brain Music, Low Energy Neurofeedback System, Nonlinear Dynamical Neurofeedback for mild cognitive impairment?
Research shows that neurofeedback training can improve memory performance in people with mild cognitive impairment, and these benefits may last beyond the training period. Additionally, neurofeedback has been shown to enhance cognitive functions in the elderly, suggesting its potential usefulness for addressing cognitive decline.12345
Is neurofeedback safe for humans?
Neurofeedback, a non-invasive method that helps people regulate their brain activity, has been studied in various forms and is generally considered safe for humans. Studies have shown it can improve cognitive functions without significant adverse effects, making it a promising tool for conditions like mild cognitive impairment.46789
How does the treatment 'Neurofeedback for Mild Cognitive Impairment' differ from other treatments for this condition?
This treatment is unique because it uses neurofeedback, a method that involves training individuals to change their brain activity using real-time feedback from their brainwaves (EEG signals). Unlike other treatments, it focuses on enhancing specific brainwave patterns to improve memory and cognitive function, and it does not rely on medication.34101112
Research Team
Marian Luctkar-Flude, PhD
Principal Investigator
Queen's University, School of Nursing
Eligibility Criteria
This trial is for individuals with Mild Cognitive Impairment (MCI). Participants should be willing to undergo neurofeedback interventions or receive usual care. Specific inclusion and exclusion criteria details are not provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive one of the neurofeedback interventions (NLD, LENS, or Brain Music) or usual care over a 5-week period
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Brain Music
- Low Energy Neurofeedback System
- Nonlinear Dynamical Neurofeedback
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kingston Health Sciences Centre
Lead Sponsor
Queen's University
Lead Sponsor
Providence Health & Services
Collaborator